Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on! PLUS nicotine pouch products, through a pilot program aimed to fast-track reviews of such products.
The authorization was the first under the pilot program that the FDA launched in September, and applies to six on! PLUS nicotine pouches, which are manufactured by Helix Innovations LLC, an Altria joint venture for the global on! PLUS nicotine pouch portfolio.
The company had applied for premarket authorization for the products in June 2024.
The decision allows the mint, tobacco and wintergreen-flavored pouches, offered in 6 mg and 9 mg nicotine strengths, to be legally sold to adults in the United States.
The FDA said its decision was based on evidence that the products contain lower levels of harmful chemicals, posing a lower risk of cancer and other serious health conditions compared to other smokeless tobacco products. The authorization applies only to the specified products and not to other Helix offerings.
Nicotine pouches, which users insert under the lip, are the fastest-growing category of tobacco products in the U.S., and are generally considered among the lowest-risk smoking alternatives given they do not involve inhalation and do not contain tobacco.
Earlier this year, 20 Zyn products, owned by Philip Morris became the first in the nicotine pouch category to receive market authorization from the FDA in the U.S.
Zyn products were approved in January, more than five years after the company first submitted its application.
Tobacco companies have invested heavily in developing and marketing alternatives to cigarettes as demand for these products grows.
"on! PLUS will resume taking new orders for retail accounts in Florida, North Carolina and Texas and on e-commerce soon," Altria said to Reuters.
Nicotine in adolescence can harm the parts of the brain that control attention, learning, mood and impulse control, according to the U.S. Centers for Disease Control and Prevention.
(Reporting by Sanskriti Shekhar and Juveria Tabassum in Bengaluru; Editing by Alan Barona)
LATEST POSTS
- 1
Africa's energy giants eye long-term gains on Iran war disruption - 2What do teens and tweens want for the holidays? E-bikes, gift cards and lip tints.
- 3Experience Is standing by: 10 Pleasant Setting up camp Areas to
- 4I served on the expert committee that advised the government on new dietary guidelines – most of our recommendations were ignored
- 5Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
- A definitive Manual for the Over-Ear Earphones
- 'A prank': Israel Police detain suspect for shooting rubber bullets at Ashkelon kindergarten
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
- Plane Passenger Allegedly Includes ‘Bomb Threat’ in Hotspot Network Name, Forces Flight to Make Emergency Landing
- US FDA investigates Takeda's blood disorder drug after pediatric death
- Palestinians forced from West Bank refugee camps left in limbo as Israeli demolitions go on
- Go on A Careful spending plan: Modest Objections for Your List of must-dos
- Israeli Chief of Staff declares new border with Gaza Strip
- Sea Ice Hits New Low in Hottest Year on Record for the Arctic
